1199P Dose modification for the management of CNS adverse events in the phase III CROWN study of lorlatinib in non-small cell lung cancer (NSCLC)
Invited conference paper presented and published in conference proceedings
Full Text
Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website |
Altmetrics Information
.
Other information
All Author(s) ListSolomon B.J., Mok T.S.K., Hayashi H., Bearz A., Penkov K.D., Wu Y-L., Arrieta O., Calella A.M., Peltz G., Polli A., Thurm H., Bauer T.M.
Name of ConferenceESMO Congress 2021
Start Date of Conference16/09/2021
End Date of Conference21/09/2021
Place of ConferenceParis
Country/Region of ConferenceFrance
Proceedings TitleAnnals of Oncology
Year2021
Month9
Volume Number32
Issue NumberSuppl 5
PagesS957 - S958
ISSN0923-7534
LanguagesEnglish-United Kingdom
